Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.25 is 60% below its 5-year average of 3.16, near the low end of its 5-year range (1.24–7.05).
As of the fiscal period ended Tuesday, March 31, 2026. 12.98% below its 12-month average of 1.44.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-03-31): 1.25.
CURRENT RATIO
1.25
CURRENT RATIO AVG TTM
1.44
CURRENT RATIO AVG 3Y
3.27
CURRENT RATIO AVG 5Y
3.16
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.98%
CURRENT VS 3Y AVG
-61.75%
CURRENT VS 5Y AVG
-60.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 800 covered companies
CURRENT VS SECTOR MEDIAN
-65.22%
vs the sector median at left
Market Cap
$112.05M
Current Ratio
12.63
TTM Avg
12.83
3Y Avg
15.22
5Y Avg
15.22
Market Cap
$109.49M
Current Ratio
5.68
TTM Avg
5.13
3Y Avg
4.85
5Y Avg
5.20
Market Cap
$112.69M
Current Ratio
2.00
TTM Avg
1.45
3Y Avg
1.62
5Y Avg
1.71
Market Cap
$112.82M
Current Ratio
3.36
TTM Avg
3.23
3Y Avg
4.24
5Y Avg
6.08
Market Cap
$108.20M
Current Ratio
5.71
TTM Avg
10.50
3Y Avg
6.63
5Y Avg
5.88
Market Cap
$108.05M
Current Ratio
0.81
TTM Avg
0.51
3Y Avg
0.77
5Y Avg
1.23
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BGM Group Ltd. (BGM) | $111.14M | 1.25 | 1.44 | 3.27 | 3.16 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $112.05M | 12.63 | 12.83 | 15.22 | 15.22 |
| Apyx Medical Corporation (APYX)vs › | $109.49M | 5.68 | 5.13 | 4.85 | 5.20 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $112.69M | 2.00 | 1.45 | 1.62 | 1.71 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.82M | 3.36 | 3.23 | 4.24 | 6.08 |
| MaxCyte, Inc. (MXCT)vs › | $113.01M | 12.26 | 9.59 | 11.55 | 11.23 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.20M | 5.71 | 10.50 | 6.63 | 5.88 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.05M | 0.81 | 0.51 | 0.77 | 1.23 |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.48M | 1.33 | 1.19 | 1.50 | 3.26 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.73M | 7.28 | 6.67 | 7.13 | 10.02 |
Current Ratio
1.25
Quick Ratio
0.65
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-03-31 | 1.25 |
| 2025-09-30 | 1.24 |
| 2025-03-31 | 1.82 |
| 2024-09-30 | 3.39 |
| 2024-03-31 | 7.05 |
| 2023-09-30 | 5.18 |
| 2023-03-31 | 2.95 |
| 2022-09-30 | 3.27 |
| 2022-03-31 | 1.94 |
| 2021-09-30 | 2.22 |
| 2021-03-31 | 4.42 |
| 2020-09-30 | 2.04 |
| 2020-03-31 | 2.29 |
| 2019-09-30 | 2.14 |
| 2019-03-31 | 2.03 |
| 2018-09-30 | 1.55 |
